Loading clinical trials...
Loading clinical trials...
A Study to Evaluate Clinical Benefits and Drawbacks of Antiretroviral Drugs as Pre-exposure Prophylaxis to Prevent HIV Infection Under Real-life Conditions Among Persons Who Pursue High-risk Sexual Practices: The Seville HIV PrEP Cohort
Conditions
Interventions
Tenofovir Disoproxil Fumarate 300 MG Oral Tablet
Locations
1
Spain
Virgen del Rocío University Hospital
Seville, Andalusia, Spain
Start Date
January 1, 2020
Primary Completion Date
December 31, 2029
Completion Date
December 31, 2030
Last Updated
September 22, 2023
NCT05947266
NCT04663152
NCT06872307
NCT05780073
NCT01532973
NCT00097006
Lead Sponsor
Hospitales Universitarios Virgen del Rocío
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions